Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee-Reference-Cited by-同舟云学术

Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee

Published:2017-02-17 Issue:12 Volume:123 Page:2360-2367
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Katzenstein Howard M.¹,Furman Wayne L.²,Malogolowkin Marcio H.³,Krailo Mark D.⁴,McCarville M. Beth⁵,Towbin Alexander J.⁶,Tiao Greg M.⁷,Finegold Milton J.⁸,Ranganathan Sarangarajan⁹,Dunn Stephen P.¹⁰,Langham Max R.¹¹,McGahren Eugene D.¹²,Rodriguez-Galindo Carlos¹³,Meyers Rebecka L.¹⁴

Affiliation:

1. Division of Pediatric Hematology/Oncology; Monroe Carell Jr. Children's Hospital at Vanderbilt University, Nashville; Tennessee

2. Department of Oncology; St Jude Children's Research Hospital, Memphis; Tennessee

3. Division of Pediatric Hematology/Oncology; University of California at Davis Comprehensive Cancer Center, Sacramento; California

4. Department of Preventive Medicine; University of Southern California Keck School of Medicine, Los Angeles; California

5. Department of Diagnostic Imaging; St Jude Children's Research Hospital, Memphis; Tennessee

6. Department of Radiology and Medical Imaging; Cincinnati Children's Hospital Medical Center, Cincinnati; Ohio

7. Division of General and Thoracic Surgery; Cincinnati Children's Hospital Medical Center, Cincinnati; Ohio

8. Department of Pathology; Baylor College of Medicine, Houston; Texas

9. Department of Pathology; Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh; Pennsylvania

10. Department of Surgery; Nemours/Alfred I. duPont Hospital for Children, Wilmington; Delaware

11. Division of Pediatric Surgery; St Jude Children's Research Hospital, Memphis; Tennessee

12. Division of Pediatric Surgery; University of Virginia Children's Hospital, Charlottesville; Virginia

13. Department of Global Pediatric Medicine; St Jude Children's Research Hospital, Memphis; Tennessee

14. Department of Pediatric Surgery; Primary Children's Medical Center, Salt Lake City; Utah

Funder

Children's Oncology Group

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy;Czauderna;Curr Opin Pediatr.,2014

2. Pretreatment prognostic factors for children with hepatoblastoma-results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1;Brown;Eur J Cancer.,2000

3. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group;Meyers;Pediatr Blood Cancer.,2009

4. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience;Ioris;Eur J Cancer.,2008

5. Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma;Douglass;Med Pediatr Oncol.,1985

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial Disparities in Treatment and Outcomes of Pediatric Hepatoblastoma;Journal of Pediatric Hematology/Oncology;2024-07-05

2. Surgical management of liver tumors;Pediatric Blood & Cancer;2024-07-02

3. FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma;Pathology - Research and Practice;2024-06

4. Construction and validation of nomogram prognostic model for predicting survival in hepatoblastoma patients: a population-based study;Updates in Surgery;2024-05-25

5. Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics;Journal of Cancer Research and Clinical Oncology;2024-04-30